
With $110M Financing Complete, Insilico Eyes Platform, Pipeline Progress
Insilico Medicine said it has completed a $110 million Series E financing, the proceeds of which are intended to help the artificial intelligence (AI) drug developer accelerate development of its pipeline and its AI platform. “On one side, resources will …